Evidence map›Paper›PMID 37202887›Full record

ArticleCNS & neurological disorders drug targets2024

The Participation of Ca

Carmen Rubio, Noel Gallardo, Vanessa Mena, Alonso Portilla, Moisés Rubio-Osornio

Abstract read
PubMed Publisher
In one paragraph

Article in CNS & neurological disorders drug targets, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Carmen RubioDepartamento de Neurofisiología, Instituto Nacional de Neurología y Neurocirugía "MVS" Ciudad de México, México.
Noel GallardoDepartamento de Neurofisiología, Instituto Nacional de Neurología y Neurocirugía "MVS" Ciudad de México, México.
Vanessa MenaDepartamento de Neurofisiología, Instituto Nacional de Neurología y Neurocirugía "MVS" Ciudad de México, México.
Alonso PortillaDepartamento de Neurofisiología, Instituto Nacional de Neurología y Neurocirugía "MVS" Ciudad de México, México.
Moisés Rubio-OsornioDepartamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía "MVS" Ciudad de México, México.
Instituto Nacional de Neurología y Neurocirugía · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBibliometric analysis allows us to quantify and evaluate scientific activity, and it has become increasingly important in all areas of scientific literature. Thanks to these analyses, we can infer where science should put greater efforts into elucidating the underlying mechanisms of diseases that have yet to be fully described or investigated.

objectiveThis paper delves into published articles related to the involvement of calcium (Ca

methodsWe followed the scientific publication on SCOPUS and analyzed the impact of publications from Latin America in the field of epilepsy and the study of Ca

resultsWe found a total of 226 works produced by Latin American countries from 1976 to 2022. The countries that have contributed the most to the topic are Brazil, Mexico, and Argentina, with occasional collaborations between them to make contributions to the study of epilepsy and Ca

conclusionThe number of authors per article ranges from 1 to 242, and neuroscience journals are the preferred target for researchers, with a predilection for publishing original articles, although 26% of the publications are review articles.

Indexed as

BibliometricsCalcium ChannelsEpilepsyAnimalsHumansLatin AmericaCalcium ChannelsBibliometriccalcium channelepilepsyGDP.modelsseizure

Identifiers

PMID37202887
OpenAlexW4377095082

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.